Health Trials

Expanded Access Use of Itacitinib to Treat a Single Patient With STAT1 Gain of Function (GOF) Disease

ConditionSTAT1 Gain-of-Function Disease
Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexNot listed
AgeNot listed
SponsorIncyte Corporation

About this trial

Expanded access use of Itacitinib to treat a single patient with aplastic anemia.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Itacitinib

Treatment groups

No treatment groups listed

Locations

This trial has no locations

Sponsors and collaborators

Incyte Corporation

Lead sponsor

Source ClinicalTrials.gov